24 alpha-ethyl-5 alpha-cholestan-3 beta-ol,
24 alpha-ethyl-5 beta-cholestan-3 alpha-ol,
beta-sitostanol,
dihydrositosterol,
sitostanol,
stigmastanol,
stigmastanol, (3beta,5beta,24S)-isomer,
STIGMASTANOL,
Fucostanol,
Dihydrositosterin,
sitostanol,
83-45-4,
Spinastanol,
beta-Sitosterol, dihydro-,
UNII-C2NJ9WO6O7,
C2NJ9WO6O7,
Dihydrositosterol,
Stigmastan-3-ol, (3b,5a)-,
NSC49081,
Stigmastan-3-ol, (3beta,5alpha)-,
24alpha-Ethylcholestanol,
5alpha-Stigmastan-3beta-ol,
5,6-Dihydro-beta-sitosterol,
beta-Sitostanol,
(3beta,5alpha)-Stigmastan-3-ol,
Stigmastan-3|A-ol,
Dihydro-beta-sitosterol,
Stigmastan-3-ol, (3b)-,
19466-47-8,
(3|A,5|A)-Stigmastan-3-ol,
EINECS 201-479-0,
NSC 49081,
Dihydro-sitosterol,
.beta.-Sitostanol,
Dihydro-|A-sitosterol,
Stigmastanol, >=95%,
Dihydro-.beta.-sitosterol,
Stigmastan-3-ol,(3b)-,
(3|A)-Stigmastan-3-ol,
.beta.-Sitosterol, dihydro-,
SCHEMBL133725,
(5alpha)-stigmastan-3beta-ol,
Stigmastan-3-ol,5.alpha.)-,
AC1L67N8,
CHEMBL252364,
CHEBI:89400,
CTK3E8459,
5.alpha.-Stigmastan-3.beta.-ol,
LGJMUZUPVCAVPU-HRJGVYIJSA-N,
5alpha-Stigmastan-3beta-ol (8CI),
ZINC4706381,
LMST01040266,
NSC-49081,
24|A-Ethyl-5|A-cholestan-3|A-ol,
AKOS016036225,
(3beta,5alpha,20S)-stigmastan-3-ol,
HY-113494,
CS-0062392,
Stigmastan-3-ol, (3beta,5alpha)- (9CI),
C19644,
UNII-3OE0DD1I5J component LGJMUZUPVCAVPU-HRJGVYIJSA-N,
UNII-B46B6DD20U component LGJMUZUPVCAVPU-HRJGVYIJSA-N,
(3S,10S,13R,17R)-17-((1R,4R)-4-Ethyl-1,5-dimethyl-hexyl)-10,13-dimethyl-hexadecahydro-cyclopenta[a]phenanthren-3-ol,
(3S,5S,8R,9S,10S,13R,14S,17R)-17-[(1R,4R)-4-ethyl-1,5-dimethyl-hexyl]-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol,
(3S,5S,8R,9S,10S,13R,14S,17R)-17-[(2R,5R)-5-ethyl-6-methylheptan-2-yl]-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol,
|A-Sistostanol,
|A-Sitostanol,
24|A-Ethylcholestanol,
AR-1J0986,
CID241572,
CS-O-31169,
22323-82-6,